The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

FREE PREVIEW | Subscribers get full access to this company

+ Show All | – Hide All

Most Recent Deal Activity

Strategic Transactions


Click a deal headline for more information | 10 of 13 | View All »

 Email Alert |   RSS Feed


  1. Alliance / Epizyme partners with BI on cancer therapeutics
    Deal Date: Nov-2018
  2. Financing / Public offering nets $81mm for Epizyme
    Deal Date: Oct-2018
  3. Financing / Epizyme nets $151mm through public stock sale
    Deal Date: Sep-2017
  4. Alliance / Epizyme to test tazemetostat combination with Roche/Genentech's Tecentriq
    Deal Date: Jun-2016 / Update Date: Jun-01-2017
  5. Financing / Epizyme closes $130mm public offering
    Deal Date: Jan-2016
  6. Financing / Epizyme nets $130.7mm through follow-on offering
    Deal Date: Mar-2015
  7. Financing / Epizyme publicly sells 3.7mm shares, nets $101mm
    Deal Date: Feb-2014
  8. Financing / Epizyme nets $71.7mm in IPO
    Deal Date: May-2013
  9. Alliance / Abbott Molecular to create companion diagnostic for Epizyme's cancer compound; deal ends
    Deal Date: Apr-2013 / Update Date: Mar-01-2015
  10. Alliance / Celgene gets rights to Epizyme’s personalized cancer therapeutics
    Deal Date: Apr-2012 / Update Date: Jul-01-2015

Deal Activity Since 1991


Click number to view associated deals


Industry Acquisitions Alliances Financings
Biotechnology 0 6 7
In Vitro Diagnostics 0 2 6
Medical Devices 0 0 0
Pharmaceuticals 0 6 7

Strategic Transactions

A comprehensive resource on biopharma, device, and diagnostic dealmaking activity, including complete Company Profiles. To set up your complimentary demonstration or trial, please e-mail Sales at: PharmaNewsSales@informa.com or call +1 (212) 520-2765

Learn More

Already a Subscriber?

Log in for complete access.

Log In
Questions?

Call Toll-Free 888-670-8900 or 908-547-2200.


Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel